Merck’s Keytruda Further Entrenches Women’s Oncology Position With Cervical Cancer Results

 
• By Alaric DeArment
  
Merck announced results from the Phase III KEYNOTE-A18 study in cervical cancer • Source: Shutterstock

More from Clinical Trials

More from R&D